Results 221 to 230 of about 2,568,476 (309)

Lifestyle Program for Breast Cancer Improves Body Composition, Fitness, and Patient-Reported Outcomes: A Randomized Clinical Trial. [PDF]

Cancers (Basel)
Powers-James C, Christie AJ, Arun B, Austin T, Babiera G, Basen-Engquist K, Carmack CL, Chaoul A, Connelly Newton L, Haddad R, Harrison C, Leung CH, Li Y, Mallaiah S, Nagarathna R, Parker PA, Perkins GH, Spelman A, Sood AK, Wagner RW, Yang P, Yeung SJ, Cohen L.   +22 more
europepmc   +1 more source

Exon 7 splicing of ERα predicts poor prognosis and increases phenotypic heterogeneity in luminal a subtype breast cancer

FEBS Open Bio, EarlyView.
ERα splice variant ERα∆7 lacks the C‐terminus, and its expression may change phenotypes of breast cancers. Our results showed that ERα∆7 is found in the luminal A subtype, and elevated ERα∆7 levels are linked to improved cell survival with lower proliferation and migration.
Long Wai Tsui, Taobo Hu, Thomson Christian Husein, Wai Hei Shek, Bingrong Chen, Depeng Wang, Shu Wang, Weichuan Yu, Xiaodan Fan, Mengping Long, Toyotaka Ishibashi   +10 more
wiley   +1 more source

Patient-reported outcomes and measures applied in individuals undergoing colonoscopy surveillance for colorectal cancer: a scoping review. [PDF]

Qual Life Res
Belay WS, Symonds EL, Azanaw MM, Molla MD, Wassie MM, Laven-Law G, Menberu MA, Ahmed M, Kaambwa B, Bulamu NB.   +9 more
europepmc   +1 more source

Development of human monoclonal antibodies against TARM1 by yeast display

FEBS Open Bio, EarlyView.
Human monoclonal antibodies against TARM1 are generated by yeast display‐guided selection. These antibodies bind to soluble and cell‐surface forms of TARM1. Also, these antibodies exhibit agonistic activity in the NFAT‐GFP reporter assay, indicating that TARM1 signaling can be functionally modulated by antibodies and suggesting TARM1 as a potential ...
Rikio Yabe, Mayumi Saeki, Masaaki Hashiguchi, Sayaka Ono, Kazuhisa Aoki, Hidetaka Tanno   +5 more
wiley   +1 more source

How to Analyze Longitudinal Patient-Reported Outcomes in Populations With High Mortality Rates. [PDF]

J Am Geriatr Soc
Baltussen JC, de Glas NA, le Cessie S, Trompet S, Mooijaart SP, Portielje JEA, van den Bos F.   +6 more
europepmc   +1 more source

Establishing an assay to evaluate d‐amino acid oxidase enzyme kinetics and inhibition using WST‐8 redox dye

FEBS Open Bio, EarlyView.
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake, Yuki Enoki, Yuka Nakazawa, Kazuaki Taguchi, Kazuaki Matsumoto   +4 more
wiley   +1 more source

Vegetative pyoderma gangrenosum: A prospective case series evaluating clinical and patient-reported outcomes. [PDF]

JAAD Case Rep
Downey K, Zhang R, Throckmorton SK, Gillespie J, Roland-McGowan J, Keller JJ, Ortega-Loayza AG.   +6 more
europepmc   +1 more source

Screening and epitope characterization of Nidogen‐2‐specific nanobodies

FEBS Open Bio, EarlyView.
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen, Qianqian Cui, Zhongyun Lan, Yingjun Wang, Shuaiying Zhao, Wenxuan Feng, Yunfeng Liu, Qiting Huang, Dongna Zhang, Jianfeng Xu   +9 more
wiley   +1 more source

Characterizing Adherence to a Mobile Health App for Patient-Reported Outcomes in Rheumatoid Arthritis. [PDF]

Rheumatol Ther
Tuzun ZS, Santacroce L, Ørbo HS, Fukui S, Tedeschi SK, Solomon DH.   +5 more
europepmc   +1 more source